USP7 and neoplasm: Our study provides biological and clinical rationale for additional preclinical testing of USP7 inhibitors in children with high-risk and relapsed NB and emphasizes the need for further research to characterize USP7′s various targets and understand the roles they play in NB tumor development and growth.